Why the study?
Targeted prevention and treatment of endothelial dysfunction in outpatient angiology may be guided by personalized characteristics from vascular ultrasound.
Case Report (n=1)
Slavinorm monotherapy may be beneficial for treating endothelial damage in patients with previous vein diseases.
Answers are grounded in this paper and cite their sources.
Outpatient ultrasound may guide targeted endothelial therapy; leaves open Slavinorm utility pending higher-level evidence.
To date, angiology suggests innovative methods of outpatient diagnosis and treatment that expands the prospects for personalized vascular care. The main pathogenetic approach in outpatient practice remains prevention and treatment of endothelial dysfunction. Personalized characteristics of endothelial damage, necessary for emergency care, become available after outpatient vascular ultrasound. These data are valuable for target therapy of endothelial dysfunction. Slavinorm based on vascular regulatory peptides has an exclusive effect on vascular endothelium among modern drugs. We present a patient with clinical deterioration after previous vein diseases. Vascular ultrasound revealed endothelial damage affecting lower limb arteries. A positive result was achieved after monotherapy with Slavinorm.
No takes yet. Share an insight, caveat, or question.
T. Alekperova (2024) conducted a case report in Endothelial damage affecting lower limb arteries (n=1). Slavinorm was evaluated on Clinical result.
Synapse has enriched 10 related papers. Consider them for comparative context: